Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) ...
Restorative neurostimulation may improve pain, disability, and quality of life in chronic low back pain. Read more.
Secondary analysis of the RESOLVE trial suggests the benefits of graded sensorimotor retraining across patient groups with ...
Explore the latest evidence from UNSW Sydney and NeuRA on non-drug, non-surgical treatments for acute and chronic low back pain (LBP). Based on a Cochrane review of over 97,000 participants, discover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results